Abu Dhabi Biobank Achieves AABB Accreditation, Enhancing Life Sciences Ecosystem

Abu Dhabi:Abu Dhabi Biobank, a collaborative initiative between the Department of Health, Abu Dhabi (DoH), and M42, has received accreditation from the Association for the Advancement of Blood and Biotherapies (AABB). This accreditation reflects the biobank's adherence to internationally recognized standards for quality and safety in blood collection, cellular therapies, and cord blood banking, thus bolstering its role in medical research, advanced therapies, and personalized healthcare.

According to Emirates News Agency, the AABB accreditation was highlighted during the Annual Conference of Ob-Gyn for Research and Development (CORD) Symposium hosted by the Abu Dhabi Biobank. The symposium assembled clinicians and experts from fields such as cord blood banking, regenerative medicine, fertility preservation, and cellular therapy.

The AABB accreditation is noted for its rigorous quality standards, which encompass donor screening, processing, storage, and long-term viability. This ensures that Abu Dhabi Biobank's protocols meet international quality and safety requirements, providing assurance for families and enhancing the foundation for clinicians and researchers in transplantation, regenerative medicine, and emerging cellular therapies.

The accreditation also aids Abu Dhabi Biobank's initiative to establish a public cord blood registry to expand access to donated units for transplantation and support research and medical treatments in the region. This effort is part of a broader strategy to integrate clinical care, research, and advanced therapeutic development within Abu Dhabi's life sciences ecosystem. The CORD Symposium engaged key opinion leaders in discussions on topics ranging from cord blood banking to advances in cell therapy and fertility preservation.

Dr. Asma Al Mannaei, Executive Director of the Health Life Sciences Sector at the Department of Health - Abu Dhabi, highlighted the accreditation as a significant milestone reflecting the quality of Abu Dhabi Biobank's infrastructure. It supports the transition from research to clinical application, promoting better health outcomes and reinforcing Abu Dhabi's position as a global hub for life sciences.

Paul Downey, General Manager of Abu Dhabi Biobank, emphasized that the AABB accreditation aligns with the biobank's standards and ambitions to develop a trusted biobanking ecosystem. This ecosystem aims to support families and foster opportunities for research and innovation in regenerative medicine and future cellular therapies.

Abu Dhabi Biobank, with the region's largest hybrid cord blood bank, collaborates with partner hospitals and research institutions to create a comprehensive biobanking ecosystem in the UAE. This ecosystem integrates cord blood banking, cryopreservation, fertility preservation, and regenerative medicine, establishing Abu Dhabi as a regional hub for biobanking and therapeutic innovation.

Recent News